Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient

Capaccio, Pasquale; Ottaviani, Francesco; Cuccarini, Valeria; Corbellino, Mario; Parravicini, Carlo; Menzo, Stefano; Schindler, Antonio; Pignataro, Lorenzo
June 2009
European Archives of Oto-Rhino-Laryngology;Jun2009, Vol. 266 Issue 6, p937
Academic Journal
Intranasal schneiderian exophytic squamous papillomatosis is rare and often secondary to human papilloma virus infection. Treatment usually consists of repeated surgical or endoscopic excisions due to recurrences. The use of intravenous or intralesional or topically applied cidofovir, a cytidine nucleotide analogue suppressing viral replication, alone or as adjuvant therapy has been proposed and described in the literature for the treatment of other human papillomavirus (HPV)-related lesions. We firstly describe a successful combined approach of surgery and topical cidofovir for recurrent nasal HPV-related exophytic squamous papillomatosis in a HIV-infected patient. As no untoward effects were encountered this therapeutical option should be considered in the management of recurrent nasal papillomatosis in HIV-infected patients.


Related Articles

  • Immunomodulatory effect of Tinospora cordifolia extract in human immuno-deficiency virus positive patients. Kalikar, M. V.; Thawani, V. R.; Varadpande, U. K.; Sontakke, S. D.; Singh, R. P.; Khiyani, R. K. // Indian Journal of Pharmacology;Jun2008, Vol. 40 Issue 3, p107 

    Objectives: To assess the safety and efficacy of TCE in human immuno-deficiency virus positive patients. Materials and Methods: Efficacy of Tinospora cordifolia extract (TCE) in HIV positive patients was assessed in randomized double blind placebo controlled trial. 68 HIV positive participants...

  • Wart Lesion in a Patient Associated with HIV Infection and Treatment under IMOD Therapy. SeyedAlinaghi, SeyedAhmad; Payvarmehr, Fatemeh; Bayanolhagh, Saeed; Mohammadoust, Saeed; Mohraz, Minoo // Acta Medica Iranica;2011, Vol. 49 Issue 6, p399 

    We report a 27-year-old hemophilic male who was HIV positive and under Highly Active Antiretroviral Therapy (HAART) along with wart lesions. When IMOD therapy started concurrently with HAART, the skin lesions disappeared.

  • Qualitative Immune Modulation by Interleukin-2 (IL-2) Adjuvant Therapy in Immunological Non Responder HIV-Infected Patients. Sabbatini, Francesca; Bandera, Alessandra; Ferrario, Giulio; Trabattoni, Daria; Marchetti, Giulia; Franzetti, Fabio; Clerici, Mario; Gori, Andrea // PLoS ONE;2010, Vol. 5 Issue 11, p1 

    Background: Treatment of HIV-infected patients with interleukin-2 (IL-2) produces significant increases in CD4 T cell counts; however an associated qualitative improvement in cells function has yet to be conclusively demonstrated. By measuring mycobacterial killing activity, we evaluated...

  • The role of Human papilloma virus (HPV) genotyping in recurrent respiratory papillomatosis in Rasoul Akram Hospital. Izadi, Farzad; Hamkar, Rasool; Ghanbari, Hadi; Abdolmotallebi, Fereshteh; Jahandideh, Hesam // Medical Journal of the Islamic Republic of Iran;May2012, Vol. 26 Issue 2, p90 

    Background: The most common laryngeal mass in children is recurrent respiratory papillomatosis (RRP). Studies have attempted to correlate viral typing and its aggressiveness. Method: 29 patients with histologically confirmed RRP enrolled in adjuvant therapies. Patients underwent several surgical...

  • Human Papillomavirus Infection and Its Association with HIV. Syrjänen, S. // Advances in Dental Research;Apr2011, Vol. 23 Issue 1, p84 

    Human papillomavirus (HPV) can infect oral mucosa, causing asymptomatic infection or warty lesions. Several case-control studies have confirmed HPV as an independent risk factor for squamous cell carcinoma. HPV-related cancers seem to have better prognoses and different risk factors than do...

  • Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the USA, National Health and Nutrition Examination Surveys, 2003-2006. Introcaso, Camille E.; Dunne, Eileen F.; Hariri, Susan; Panicker, Gitika; Unger, Elizabeth R.; Markowitz, Lauri E. // Sexually Transmitted Infections;Sep2014, Vol. 90 Issue 6, p505 

    Background A vaccine is available to prevent human papillomavirus (HPV) 6, 11, 16 and 18; in the prevaccine era, seropositivity to vaccine types is a measure of natural exposure. Methods We describe HPV seropositivity in the USA among 14-59-year-olds using the 2003-2006 National Health and...

  • Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives. Toft, Lars; Tolstrup, Martin; Storgaard, Merete; Østergaard, Lars; Søgaard, Ole S. // Sexual Health (14485028);2014, Vol. 11 Issue 6, p511 

    Background: Men and women with HIV infection are at increased risk of developing cancers associated with human papillomavirus (HPV). The two licensed prophylactic HPV vaccines protect against de novo infection with HPV-16 and HPV-18, which cause the majority of HPV-associated cancers. Currently,...

  • Don't be too aggressive when you treat papillomavirus, especially in younger women.  // Modern Medicine;Jun96, Vol. 64 Issue 6, p38 

    Offers tips to physicians presented at the 44th annual clinical meeting of the American College of Obstetricians and Gynecologists held on April 27 and May 1, 1996 concerning the medical management of papillomavirus in younger women. Education and follow-up; Treatment of lesions; Biopsy;...

  • Verrucas: Guidelines for Management. Leman, J.A.; Benton, E. // American Journal of Clinical Dermatology;May/Jun2000, Vol. 1 Issue 3, p143 

    Most people will experience infection with human papilloma virus (HPV) at some point in their life. Diagnosis, based on clinical examination, is usually straight forward. Treatment can, however, be challenging. Indications for treatment include pain, interference with function, cosmetic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics